We are live on ! Find out more
PRTC

PureTech Health
PRTC

Delisted

PRTC was delisted on the 20th of May, 2026.

Back to rankings

4 hedge funds and large institutions have $1.33M invested in PureTech Health in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0.02% less ownership

Funds ownership: 0.03% → 0.01% (-0.02%)

66% less capital invested

Capital invested by funds: $3.98M → $1.33M (-$2.64M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
PCM
Portolan Capital Management
Massachusetts
-$2.06M
2
MIFH
Migdal Insurance & Financial Holdings
Israel
-$6.19K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$1.11M – – –
PCM
2
Portolan Capital Management
Massachusetts
$213K -$2.06M -46,672 -89%
MIFH
3
Migdal Insurance & Financial Holdings
Israel
$9K -$6.19K -140 -38%
UBS Group
4
UBS Group
Switzerland
$1K – – –

PRTC Hedge Fund Activity: Q4 2021 in Review

4 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2021, worth a combined $1.33M — down 66% from $3.98M a quarter earlier.

Fund positioning in PRTC was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Portolan Capital Management, cutting an estimated $2.06M.

  • 4 institutional investors held PureTech Health (PRTC) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $1.33M of PureTech Health stock for Q4 2021, down 66% quarter-over-quarter.
  • 0 funds opened new PureTech Health positions in Q4 2021 and 0 closed out.
  • The largest PureTech Health seller in Q4 2021 was Portolan Capital Management, an estimated $2.06M sold.

Based on aggregated 13F filings for Q4 2021.